** Synthetic biological products maker Twist Bioscience's TWST.O shares rise 13.8% to $41.99 premarket
** Co's fiscal Q4 rev of $84.7 mln beats analysts' est of $82.2 mln - LSEG
** Co reports fiscal Q4 loss of 59 cents/share, smaller than analysts' est of a loss of 71 cents/share - LSEG
** Co forecasts rev of $367 mln to $377 mln for fiscal year ending Sept 2025 vs est of $371.4 mln - LSEG
** TWST also forecasts Q1 FY25 rev of ~87 mln
** Nine of 12 brokerages rate the stock "buy" or higher, 2 "hold" and 1 "sell"; their median PT is $54 - LSEG
** As of last close, stock has risen 0.1% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。